Table 3.
Summary of fatal and nonfatal cases with comorbidity in COVID-19 patients
| Comorbidity | Cao et al. | Chen T, et al. | Benelli, et al. | Nikpour., et al. | Total |
|---|---|---|---|---|---|
| N = Fatal (Nonfatal) cases | |||||
| Total (N =) | 13 (34) | 71 (62) | 61 (195) | 201 (2,240) | 346 (2,531) |
| CVD | 6 (5) | 21 (7) | 28 (65) | 4 (33) | 59 (110) |
| HTN | 11 (17) | 54 (39) | 48 (145) | 8 (51) | 121 (252) |
| Diabetes | 6 (5) | 24 (23) | 25 (42) | 11 (102) | 66 (172) |
| COPD | 4 (6) | 11 (7) | 10 (38) | 9 (51) | 34 (102) |
| Cancer | 1 (3) | 5 (2) | 9 (24) | 1 (16) | 16 (45) |
| CKD | 3 (1) | 1 (4) | 11 (11) | 3 (15) | 18 (31) |
| Other | 2 (4) | 8 (12) | 0 | 2 (17) | 12 (33) |
| OR [95% CI], P value |
4.88 [1.47-16.21] <.05 |
2.70 [1.64-4.43] <.05 |
4.10 [2.08-8.06] <.05 |
0.62 [0.43-0.89] <.05 |
0.83 [0.60-0.99] <.05 |